HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: adc.2006.113886v1 93/4/303    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in ADC Online Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bradbury, M J E Articles by Williams, M D Search for Related Content PubMed PubMed Citation Articles by Bradbury, M J E Articles by Williams, M D

A comparative study of anticoagulant control in patients on long-term warfarin using home and hospital monitoring of the international normalised ratio

Department of Haematology, The Birmingham Children’s Hospital NHS Trust, Birmingham, UK

Correspondence to:
Dr M D Williams, Department of Haematology, The Birmingham Children’s Hospital NHS Trust, Birmingham, UK; mike.williams{at}bch.nhs.uk

Background: Capillary whole-blood point-of-care prothrombin-INR (PT-INR) testing at home is an alternative to hospital-based monitoring for patients on lifelong warfarin.

Aim: To retrospectively assess the safety and efficacy of home point-of-care testing for children on long-term warfarin.

Method: All patients who had been on point-of-care home monitoring for at least 6 months were included in the study. Their warfarin control was assessed while on home monitoring and compared to that achieved in a similar period before changing from hospital monitoring.

Results: Thirty-seven patients were studied for a mean of 1.0 year on clinic monitoring and 1.07 years on home monitoring. The clinic monitoring tests were within a therapeutic range for a median 70.0 (inter-quartile range 34.5) and the home monitoring were within range for median 75.0 (inter-quartile range 44.5). There were no major haemorrhagic or thrombotic complications in either group during the study period. Only 2.3% of all tests had an INR greater than 6.0 with no statistical differences seen between the clinic and home monitoring groups.

Conclusion: Home point-of-care testing in children on lifelong warfarin is safe, effective and offers a number of advantages to the child and family. Ongoing training and support for the families is essential for this service.